Prevalence and patterns of congenital heart diseases in Africa: a systematic review and meta-analysis protocol

Aurel T Tankeu1, Jean Joel R Bigna2,3, Jobert Richie N Nansseu4,5

  • 1Department of Internal Medicine and Specialties, Faculty of Medicine and Biomedical Sciences, Yaoundé, Cameroon.

BMJ Open
|February 16, 2017
PubMed

Insights

This systematic review examines congenital heart diseases (CHD) in Africa. It aims to determine the prevalence and patterns of CHD to improve preventive strategies for children and adolescents.

Area of Science:

  • Cardiology
  • Public Health
  • Epidemiology

Background:

  • Congenital heart diseases (CHD) are a significant cause of illness and death in young people in Africa.
  • Accurate epidemiological data are crucial for developing effective prevention and treatment strategies.
  • Existing data on CHD prevalence and patterns across Africa are limited.

Purpose of the Study:

  • To systematically review and meta-analyze the prevalence of CHD in Africa.
  • To identify the main patterns of congenital heart diseases across different African regions.
  • To provide a comprehensive epidemiological overview to inform public health interventions.

Main Methods:

  • Systematic review and meta-analysis of published studies (1986-2016).
  • Inclusion of cross-sectional, case-control, and cohort studies with echocardiographic confirmation of CHD.
  • Data extraction and bias assessment by two independent reviewers, with random-effects meta-analysis for prevalence estimation.

Main Results:

  • The review will synthesize prevalence data from diverse African populations.
  • Analysis will identify regional variations in CHD patterns.
  • Publication bias will be assessed using funnel plots and Egger's test.

Conclusions:

  • This study will establish a baseline for CHD burden in Africa.
  • Findings will guide targeted public health initiatives and resource allocation.
  • The results will be disseminated through a peer-reviewed publication.
Abstract

Related Concept Videos

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
842
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
699
Study Designs in Epidemiology01:20

Study Designs in Epidemiology

Epidemiological study designs are fundamental tools for investigating the distribution, determinants, and control of health conditions in populations. They help researchers understand the relationships between exposures and outcomes, and they broadly fall into two categories: "observational" and "experimental" studies.
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...
1.3K
Prevalence and Incidence01:08

Prevalence and Incidence

In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
2.2K
Pulmonary Hypertension: Classification and Pathogenesis01:30

Pulmonary Hypertension: Classification and Pathogenesis

Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
745
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
593